Scinai Immunotherapeutics Ltd. (SCNI)
0.4844
+0.04
(+9.84%)
USD |
NASDAQ |
Nov 09, 16:00
0.479
-0.01
(-1.11%)
After-Hours: 19:36
Scinai Immunotherapeutics Gross Profit Margin (Quarterly) : -32.38% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -32.38% |
| June 30, 2026 | -272.2% |
| March 31, 2026 | -228.6% |
| December 31, 2025 | 0.00% |
| September 30, 2025 | 0.00% |
| Date | Value |
|---|---|
| June 30, 2025 | 0.00% |
| March 31, 2025 | 38.90% |
| December 31, 2024 | -323.4% |
| September 30, 2024 | -444.6% |
| June 30, 2024 | -232.4% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Compugen Ltd. | -3.54% |
| Pluri, Inc. | 21.49% |
| Evogene Ltd. | -2.31% |
| CollPlant Biotechnologies Ltd. | -604.6% |
| Regentis Biomaterials Ltd. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -23.60% |
| Return on Assets | -16.09% |
| Return on Invested Capital | -18.14% |
| Profit Margin (Quarterly) | -106.0% |
| Operating Margin (Quarterly) | -105.1% |
| Return on Net Operating Assets | -19.59% |